{"id":"6d560042ed8f","type":"article","url":"https://hartvaat.nl/2024/08/06/doac-bij-heartmate-3-lvad-eerste-gerandomiseerde-trial/","title":"DOAC bij HeartMate 3 LVAD: eerste gerandomiseerde trial","title_en":"A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study.","category":"hartfalen","category_label":"Hartfalen","professions":["apotheker","cardioloog"],"tags":["pathfinder-trial"],"journal":"Circulation","doi":"10.1161/CIRCULATIONAHA.124.069726","source_url":"https://doi.org/10.1161/CIRCULATIONAHA.124.069726","authors":["Ivan Netuka","Zuzana Tucanova","Peter Ivak","Stanislav Gregor","Dushan Michael Kolesar","Tomas Marek","Vojtech Melenovsky","Jana Binova","Zora Dorazilova","Marketa Hegarova","Martina Podolec","Hynek Riha","Jean M Connors","Mandeep R Mehra"],"significance":7,"published":"2024-08-06","source_date":"2024-08-06","image":"","kennis":[],"congress":"","summary_en":"This first randomized trial of DOAC therapy in patients with the HeartMate 3 LVAD explored whether direct oral anticoagulants can replace warfarin for anticoagulation in mechanically supported patients, potentially simplifying long-term management.","created":"2026-07-03T10:31:05Z","updated":"2026-07-03T13:30:08Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Eerste gerandomiseerde trial van DOAC-therapie bij volledig magnetisch geleviteerde LVAD (HeartMate 3). De studie onderzoekt of DOAC's het antistollingsmanagement bij LVAD-patiënten kunnen vereenvoudigen.","abstract_original":""}